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Background: Total laparoscopic hysterectomy (TLH) is safe and cost effective in early stage endometrial cancer when compared to total abdominal hysterectomy (TAH). In non-randomised data it is often hypothesised that older and obese patients benefit most from TLH. Aim of this study is to analyse whether data support this assumption to advice patients, clinicians and policy makers.
Methods: Data of 283 patients enrolled in a randomised controlled trial comparing TAH versus TLH in early stage endometrial cancer were re-analysed. Randomisation by sequential number generation was done centrally, with stratification by trial centre. Using multivariate analysis, predictors of major complications and conversions to laparotomy were assessed.
For the cost effectiveness analysis, subgroups of patients were constructed based on age and body mass index (BMI). For each subgroup, costs per major complication-free patient were estimated, using incremental cost effect ratios (extra costs per additional effect).
Results: Older (odds ratio (OR): 1.05; 1.01-1.09) and obese (OR: 1.05; 1.01-1.10) patients had a higher risk to develop complications, for both groups. In obese (OR: 1.17; 1.09-1.25) patients and patients with a previous laparotomy (OR: 3.45; 1.19-10.04) a higher risk of conversion to laparotomy was found. For patients >70 years of age and patients with a BMI over 35 kg/m 2 , incremental costs per major complication-free patients were €16 and €54 for TLH compared to TAH, respectively.
Conclusion:
In general, TLH should be recommended as the standard surgical procedure in early stage endometrial cancer, also in patients >70 years of age. In obese patients with a BMI >35 kg/m 2 TLH is not cost effective because of the high conversion rate. A careful consideration of laparoscopic treatment is needed for this subgroup. Surgeon experience level may influence this choice.
Ó 2011 Elsevier Ltd. All rights reserved. 1.
Introduction
Endometrial cancer is the third most common cancer in women in Western countries, accounting for 6-9% of all cancer types in women. 1 Predominantly, endometrial cancer occurs in postmenopausal women and 90% of the patients are over 50 years of age. [2] [3] [4] The incidence increases in overweight individuals, and almost half of the patients have a body mass index (BMI) >30 kg/m 2 . In addition, a significant number of patients present with co-morbidity. Because postmenopausal bleeding is an early sign, the majority (75%) of patients are diagnosed at an early stage. Standard treatment for patients with early endometrial cancer is total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH) with or without lymph node dissection through a vertical midline incision. The role of laparoscopy has been discussed in several randomised reports for various gynaecological disorders and for endometrial cancer as well. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] We recently performed a randomised controlled trial comparing total laparoscopic hysterectomy (TLH) by proven skilled surgeons and TAH, which indicated that TLH is cost effective without evidence of benefit in terms of complications. Furthermore, TLH was associated with significantly less blood loss, less use of pain medication, a shorter hospital stay, and a faster recovery than TAH. 2, 17 In literature, it is often hypothesised that obese and elder patients do benefit more from TLH than younger patients. [18] [19] [20] The aim of the current analysis is to test whether this hypotheses is supported by our data from this randomised trial.
Patients and methods
Study design and patients
A detailed description of the study protocol has been reported previously. 21 This study concerned a multicentre prospective randomised clinical phase 3 trial, with 24 certified gynaecologists participating in 21 centres. 2 The standard surgical approach TAH was compared to the experimental surgical procedure TLH. Early stage endometrial cancer patients (endometrioid adenocarcinoma grade 1 or 2, clinically stage I disease), age 18 years and older were eligible for this trial. Eligible patients, enrolled by the participating gynaecologists, were randomly allocated to the intervention group (TLH) or control group (TAH). Randomisation was done via a computerised, unbalanced (2:1) method, favouring TLH to obtain more data on the experimental laparoscopic procedure. Randomisation by sequential number generation was done centrally in alternate blocks of six and three participants, with stratification by trial centre. Study coordinators, patients, gynaecologists and members of the panel were not masked to intervention after assignment. 2, 21 Amongst 283 randomised patients (TLH n = 187; TAH n = 96), 279 (TLH n = 185; TAH n = 94) were included in the intention-to-treat analysis (Fig. 1 ). In each arm two patients were randomised, although it was known before randomisation that they did not fulfil the inclusion criteria. These patients were not included in the intention-to-treat analysis. 
Methods
Assessment of effects
Our primary measure of effect was major complication-free rate (i.e. the percentage of patients without major complications). Since this concerns a secondary analysis, we focused on the main health outcome, major complication-free rate, only. The results of the primary outcome measure were published previously. 2 The occurrence of a conversion (from laparoscopy to laparotomy) was reported in the case record form (CRF). No imputation techniques were used since baseline characteristics and the health outcome did not differ between complete and missing data. 
Assessment of costs
Resource use data included procedure costs (time, housing, equipment, disposables, and overhead), hospital stay and costs incurred during the postoperative period. A CRF was used to gather these in-hospital medical costs. Further specification of resource units and valuation was reported previously. 17 The patient questionnaires were used to collect information on costs of additional home care, professional as well as informal. 17 Because of the composition of the patient group, characterised by women >60 years (Table 1) , productivity losses were not included in the economic evaluation. In the present study, total costs and effects were calculated up to 6 weeks after surgery.
Design of the cost effect analysis (CEA)
An economic evaluation was conducted alongside the randomised clinical trial and performed from a societal perspective, meaning all relevant costs both inside and outside the hospital were included. A CEA was undertaken to evaluate the balance between costs and effects of both treatment modalities over a 3 months time horizon. The CEA depicts the additional costs per major complication-free patient that need to be invested in the situation that TAH is replaced by TLH. Costs and incremental cost effect ratio (ICER) for major complications for complete cost effect pairs were calculated. With regard to complication rate, both costs and results were re-calculated to the level of 100 patients. Finally, cost-effectiveness planes were constructed depicting 5000 bootstrap replications of the selected subgroups.
Statistical analysis
All patients were analysed according to the intention-to-treat principles. Univariate logistic regression analyses, adjusted for treatment (i.e. TLH or TAH) were performed with a patient with major complication(s) or a patient in the TLH group who underwent a conversion to laparotomy as dependent variables and the baseline characteristics age, BMI, previous laparotomy, co-morbidity and International Federation of Gynaecologists and Obstetricians (FIGO) stage as independent variables. Odds ratios (OR's) and 95% confidence intervals (95% CIs) were calculated. Multivariate logistic analysis was performed by using a backward step model with major complication or conversion to laparotomy as dependent variables and the statistically significant related variables, as assessed in the univariate logistic regression analysis, as independent variables. Variables were excluded from the model if p P 0.05. In accordance with the assessed predictors from multivariate analysis, independent predictors were selected to create subgroups for the cost effectiveness analysis. One outlier in the TLH group due to extreme long hospitalisation and additional home care was deleted from the age subgroup, to prevent distortion of cost-effectiveness in this relatively small group. The mean total cost of this outlier was €15.234, whereas mean costs in the total group without the outlier was €3.500 (1.446-8.200 ).
All tests were two-sided and probability values of <0.05 were considered to be statistically significant. Analyses were performed using the SPSS software package, version 17.0 for Windows (SPSS Inc., Chicago, Illinois, USA) and Microsoft Excel (2003).
Results
Study group and surgeons
Baseline characteristics were equally distributed between both treatment arms ( 
Predictors of major complications and conversions
In multivariate analysis, a higher age (OR: 1.05 per increasing year; 95% CI: 1.01-1.09) and BMI (OR: 1.05 per increasing point BMI; 95% CI: 1.01-1.10) were both independently associated with the occurrence of major complications, adjusted for surgical technique (TLH or TAH) ( Table 2) .
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Conversions to laparotomy occurred in 20 (10.8%) of all laparoscopy patients. Both higher BMI (OR: 1.17 per increasing point kg/m 2 ; 95% CI: 1.09-1.25) and having had a previous laparotomy (OR: 3.45; 95% CI: 1.19-10.04) were independent predictors of the occurrence of a conversion (Table 2) .
Based on the independent predictors of the effect measures, the following subgroups were constructed for the cost effectiveness analysis; (1) patients over 70 years of age (n = 61; TLH = 38, TAH = 23) and (2) patients with a BMI over 35 kg/m 2 (n = 55; TLH = 31, TAH = 24) (Fig. 2) .
Health outcome measures in elder or obese patients
The major complication rate in patients over 70 years of age was 28.9% (11/38) 
3.4.
Cost effectiveness analysis in elder and obese patients
In the total population, with a mean difference of €-6 (i.e. lower costs for TLH) in costs and a mean difference of 0.16% (less complications in TLH arm) in major complication-free rate, the ICER generated is €-37 for laparoscopy, based on the bootstrap simulations (TLH n = 142; TAH n = 70). For patients over 70 years of age, the mean difference in costs for was €136 (i.e. higher costs for TLH) with a mean difference in major complication-free rate of 8.46% (i.e. less complications in TLH arm), generating an ICER of €16 for laparoscopy (TLH n = 26; TAH n = 15). From the bootstrapped cost effectiveness plane (Fig. 3A) it can be seen that the ICER is located at the North East quadrant. For patients with a BMI over 35 kg/m 2 subgroup, the mean difference in costs for the BMI subgroup was €-272 (i.e. lower costs for TLH), with a mean difference in major complication-free rate of )5.07% for laparoscopy (i.e. more complications in TLH arm), generating an ICER of €54 for TLH (TLH n = 23; TAH n = 18). This ICER is located in the South West quadrant of the cost effectiveness plane (Fig. 3B) . ) have a substantial higher conversion rate after laparoscopy compared to thinner patients. TLH is cost effective in patients over 70 years of age, but not in patients with a BMI >35 kg/m 2 based on major complication-free rate as primary measure of effect. In the latter, TLH is less costly with no additional effect compared to TAH meaning that TLH is by definition not cost effective in obese patients. Our data showed that obesity is a predictor of higher major complication rates, irrespective of the surgical technique used (i.e. TAH or TLH). The major complication in obese patients treated by laparoscopy (25.8%: 10.4-41.2%) or laparotomy (25.0%: 7.7-42.3%) is comparable. In contrast with our results, in a retrospective single centre study comparing both surgical techniques in obese women with endometrial cancer, substantially more complications occurred after an abdominal approach (58.1%: 40.7-75.5%) when compared to laparoscopy (21.3%: 9.6-33.0%). 18 Furthermore, another study showed that endometrial cancer in severely obese can be managed safely by laparoscopy. Neither the conversion rate, nor the complication rate was higher for this specific group. 22 Our study indicated that age is a predictor of the occurrence of major complications, though the major complication rates for laparoscopy (28.9%: 14.5-43.3%) and laparotomy (21.7%: 4.9-38.5%) are comparable. In a retrospective series of Scribner et al. in elder women with endometrial cancer, fewer complications were observed in the laparoscopy group (26.9%: 16.3-37.5%) than in the laparotomy group (62.2%: 48.0-76.4%). 19 However, due to the retrospective and non-randomised design of these studies, they are prone to selection and information bias. A small randomised single centre trial in endometrial cancer (n = 122) indicated that in a subgroup of obese, elder patients with co-morbidity, surgical technique was the only independent predictor of complications in favour of laparoscopy, which is not in agreement with our results as shown in Table 2 . 20 Our results indicate that the probability of a conversion increases with higher BMI. In patients with a BMI over 35 kg/m 2 , 32.3% of all laparoscopic procedures were converted to a laparotomy. Consistent with our finding, a large multi-institutional randomised trial (GOG2222) in clinical stage I and IIA endometrial cancer patients showed that the risk of conversion was higher with higher BMI, but also with higher age and metastatic disease. 23 The fact that metastatic disease was not related to conversion in our study might be because of the fact that we included only clinical stage I patients and hence advanced disease was very rare (3.0%). In the GOG2222 study, a lymphadenectomy was performed as part of the standard surgical treatment in both arms, which makes the surgical procedure more advanced, complex and prolonged, and therefore might lead to higher conversion and complication rates. To our knowledge, this is the first analysis based on patient profiles from a rigorously setup randomised study comparing safety and cost effectiveness in early stage endometrial cancer patients. Despite the fact that the present analyses were performed in relatively small subgroups of obese and elder women, the result of this study can be used by clinicians and patients in decision making and might result in maximal health gain for patients, surgeons and policy makers. There is no evidence of benefit observed in terms of major complications in the subgroups between TLH and TAH. TLH is cost effective in patients over 70 years of age, but not in patients with a BMI over 35 kg/m 2 , based on major complication-free rate as primary measure of effect. In general, TLH should be recommended as the standard surgical procedure in early stage endometrial cancer. In obese patients with a BMI >35 kg/m 2 TLH is not cost effective because of the high conversion rate. A careful consideration of laparoscopic treatment is needed for this subgroup. Surgeon experience level may influence this choice.
